化学
药品
药物发现
组合化学
制药工业
药理学
计算生物学
小分子
制药工业
纳米技术
药品审批
梅德林
化学合成
作者
Scott P. France,Erick A. Lindsey,Emma L. McInturff,Simon Berritt,Andrew C. Flick,Sarah J. Fink,Tony Gibson,Kaitlyn C. Gray,Aran K. Hubbell,Amber M. Johnson,Yiyang Liu,Subham Mahapatra,Rebecca B. Watson,Zhiyao Zhou
标识
DOI:10.1021/acs.jmedchem.6c00287
摘要
In 2024, thirty-nine new small molecule drugs were approved worldwide. A brief introduction to each new drug is followed by the synthetic details that highlight the most scalable routes available at the time of publication in patents or primary literature. Structural complexity varies widely across the drugs that are included in the review, as do the methods of synthesis used to access these new drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI